Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 10, 2011, Pages 1111-1116

  Uzar, Ertugrul ^a   Evliyaoglu, O ^a   Yucel, Y ^a   Ugur Cevik, M ^a   Acar, A ^a   Guzel, I ^a   Islamoglu, Y ^a   Colpan, L ^a   Tasdemir, N ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Biomarker; Cytokine; Migraine; Pathogenesis; Pro BNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 82455174249     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. PANCONESI A, BARTOLOZZI ML, GUIDI L. Migraine pain: reflections against vasodilatation. J Headache Pain 2009; 10: 317-325.
2. YILMAZ IA, OZGE A, ERDAL ME, EDGÜNLÜ TG, CAKMAK SE, YAUN OO. Cytokine polymorphism in patients with migraine: some suggestive clues of migraine and inflammation. Pain Med 2010; 11: 492-497.
3. KURTH T, GAZIANO JM, COOK NR, LOGROSCINO G, DIENER HC, BURING JE. Migraine and risk of cardiovascular disease in women. JAMA 2006; 296: 283-291.
4. KURTH T, SCHÜRKS M, LOGROSCINO G, GAZIANO JM, BURING JE. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. Br Med J 2008; 337: a636.
5. SCHER AI, TERWINDT GM, PICAVET HS, VERSCHUREN WM, FERRARI MD, LAUNER LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005; 64: 614-620.
6. ETGEN T, BAUM H, SANDER K, SANDER D. Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Stroke 2005; 36: 270-275.
7. SCHILLACI G, SARCHIELLI P, CORBELLI I, PUCCI G, SETTIMI L, MANNARINO MR, CALABRESI P, MANNARINO E. Aortic stiffness and pulse wave reflection in young subjects with migraine: A case-control study. Neurology 2010; 75: 960-966.
8. VIDALÓN M. Subclinical left ventricular dysfunction in migraine attacks. Headache 2006; 46: 46-56.
9. LEUNG L, CAHILL CM. TNF-alpha and neuropathic pain-a review. J Neuroinflammation 2010; 7: 27.
10. KOÇER A, KOÇER E, MEMI O ULLARI R, DOMAÇ FM, YÜKSEL H. Interleukin-6 levels in tension headache patients. Clin J Pain 2010; 26: 690-693.
11. BRUNO PP, CARPINO F, CARPINO G, ZICARI A. An overview on immune system and migraine. Eur Rev Med Pharmacol Sci 2007; 11: 245-248.
12. PERINI F, D'ANDREA G, GALLONI E, PIGNATELLI F, BILLO G, ALBA S, BUSSONE G, TOSO V. Plasma cytokine levels in migraineurs and controls. Headache 2005; 45: 926-931.
13. VALLEJO R, TILLEY DM, VOGEL L, BENYAMIN R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract 2010; 10: 167-184.
14. MUNNO I, MARINARO M, BASSI A, CASSIANO MA, CAUSARANO V, CENTONZE V. Immunological aspects in migraine: increase of IL-10 plasma levels during attack. Headache 2001; 41: 764-767.
15. LIMA MM, PADULA NA, SANTOS LC, OLIVEIRA LD, AGAPEJEV S, PADOVANI C. Critical analysis of the international classification of headache disorders diagnostic criteria (ICHD I-1988) and (ICHD II-2004), for migraine in children and adolescents. Cephalalgia 2005; 25: 1042-1047.
16. EMPL M, SOSTAK P, RIEDEL M, SCHWARZ M, MULLER N, FORDERREUTHER S, STRAUBE A.Decreased sTNF-RI in migraine patients? Cephalalgia 2003; 23: 55-58.
17. KAWASAKI Y, ZHANG L, CHENG JK, JI RR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008; 28: 5189-5194.
18. KOÇER A, MEMI O ULLARI R, DOMAÇ FM, ILHAN A, KOÇER E, OKUYUCU S, OZDEMIR B, YÜKSEL H. IL-6 levels in migraine patients receiving topiramate. Pain Pract 2009; 9: 375-379.
19. BOĆKOWSKI L, SOBANIEC W, ZELAZOWSKA-RUTKOWSKA B. Proinflammatory plasma cytokines in children with migraine. Pediatr Neurol 2009; 41: 17-21.
20. VAN HILTEN JJ, FERRARI MD, VAN DER MEER JW, GUSMAN HJ, LOOU BJ Jr. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 1991; 171: 184-188.
21. COVELLI V, MUNNO I, PELLEGRINO NM. Are TNF-alpha and IL-1b relevant in the pathogenesis of migraine without aura? Acta Neurol (Napoli) 1991; 13: 205-211.
22. VAN HILTEN JJ, FERRARI MD, VAN DER MEER JW, GUSMAN HJ, LOOU BJ Jr. Plasma interleukin-1, tumour necrosis factor and hypothalamic-pituitary-adrenal axis responses during migraine attacks. Cephalalgia 1991; 11: 65-67.
23. VALLEJO R, TILLEY DM, VOGEL L, BENYAMIN R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract 2010; 10: 167-184.
24. TASDEMIR N, ULUG NC, DOGAN BB. Immunological parameters in migraine patients. Turkiye Klinikleri J Med Sci 2009; 29: 1623-1629.
25. FIDAN I, YÜKSEL S, YMIR T, IRKEÇ C, AKSAKAL FN. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 2006; 171: 184-188.
26. BØ SH, DAVIDSEN EM, GULBRANDSEN P, DIETRICHS E, BOVIM G, STOVNER LJ, WHITE LR. Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia 2009; 29: 365-372.
27. STEINBERG A, SJÖSTRAND C, SOMINANDA A, FOGDELLHAHN A, NILSSON REMAHL AI. Interleukin-2 gene expression in different phases of episodic cluster headache - a pilot study. Acta Neurol Scand 2010. doi: 10.1111/j.1600-0404.2010. 01434.x
28. SHIMOMURA T, ARAGA S, ESUMI E, TAKAHASHI K. Decreased serum interleukin-2 level in patients with chronic headache. Headache 1991; 31: 310-313.
29. TIETJEN GE. Migraine as a systemic vasculopathy. Cephalalgia 2009; 29: 987-996.
30. GUDMUNDSSON LS, SCHER AI, ASPELUND T, ELIASSON JH, JOHANNSSON M, THORGEIRSSON G, LAUNER L, GUDNASON V. Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study. Br Med J 2010; 341: c3966. doi: 10.1136/bmj.c3966.
31. COOK NR, BENSENOR IM, LOTUFO PA, LEE IM, SKERRETT PJ, CHOWN MJ, AJANI UA, MANSON JE, BURING JE. Migraine and coronary heart disease in women and men. Headache 2002; 42: 715-727.
32. VELAGALETI RS, VASAN RS. Heart failure in the twenty-first century: is it a coronary artery disease or hypertension problem? Cardiol Clin 2007; 25: 487-495.
33. MAISEL AS, KRISHNASWAMY P, NOWAK RM, MCCORD J, HOLLANDER JE, DUC P, OMLAND T, STORROW AB, ABRAHAM WT, WU AH, CLOPTON P, STEG PG, WESTHEIM A, KNUDSEN CW, PEREZ A, KAZANEGR A R, HERRMANN HC, MCCULLOUGH PA; BREATHING NOT PROPERLY MULTINATIONALSTUDY INVESTIGATORS. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
34. ISHII J, NOMURA M, NAKAMURA Y, NARUSE H, MORI Y, ISHIKAWA T, ANDO T, KUROKAWA H, KONDO T, NAGAMURA Y, EZAKI K, HISHIDA H. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 2002; 89: 691-695.
35. GALVANI M, OTTANI F, OLTRONA L, ARDISSINO D, GENSINI GF, MAGGIONI AP, MANNUCCI PM, MININNI N, PRANDO MD, TUBARO M, VERNOCCHI A, VECCHIO C; ITALIAN WORKING GROUP ON ATHEROSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY AND THE ASSOCIAZIONE NAZIONALE MEDICI CARDIOLOGI OSPEDALIERI (ANMCO). N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 2004; 110: 128-134.
36. SCHILLACI G, SARCHIELLI P, CORBELLI I, PUCCI G, SETTIMI L, MANNARINO MR, CALABRESI P, MANNARINO E. Aortic stiffness and pulse wave reflection in young subjects with migraine: A case-control study. Neurology 2010; 75: 960-966.
37. CHATZIS D, TSIOUFIS C, TSIACHRIS D, TAXIARCHOU E, LALOS S, KYRIAKIDES Z, TOUSOULIS D, KALLIKAZAROS I, STEFANADIS C. Brain natriuretic peptide as an integrator of cardiovascular stiffening in hypertension. Int J Cardiol 2010; 141: 291-296.
38. MA KK, OGAWA T, DE BOLD AJ. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004; 36: 505-513.
39. SOLUS J, CHUNG CP, OESER A, AVALOS I, GEBRETSADIK T, SHINTONI A, RAGGI P, SOKKA T, PINCUS T, STEIN CM. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum 2008; 58: 2662-2669.